Gynecologic Oncology at UCLA
The Division of Gynecologic Oncology at UCLA is dedicated to providing patients with individualized care.
Endometrial Cancer Care | UCLA Gynecologic Oncology
UCLA gynecologic oncologist, Dr. Sanaz Memarzadeh discusses endometrial cancer.
We understand that each woman has unique medical and emotional needs.
In order to best address these needs, we work closely with highly qualified experts who specialize in a variety of medical fields. Weekly meetings are held to discuss the best management for patients who need treatment. At these meetings, the gynecologic oncologists are joined by specialists in the fields of medical oncology, radiation oncology, pathology, clinical trials, nursing and social services.
|Download Brochure (PDF)|
We work together to evaluate each patient’s situation and to customize a treatment plan that is in the best interests of each individual patient. This cooperative team approach has contributed to UCLA being named Best Hospital in West by U.S. News and World Report for 19 years and for the UCLA Jonsson Comprehensive Cancer Center to be recognized as Best Cancer Center in California for 7 consecutive years.
One research goal at the G.O. Discovery Lab is to improve the way we treat patients with gynecologic cancers. As part of this goal, we are looking for effective and better tolerated therapies for endometrial cancer.
|Download Clinical Update(PDF)|
Endometrial cancer (a form of uterine cancer) is the most common gynecologic cancer in the U.S. It originates from the endometrium, a specialized and hormonally sensitive cell layer that lines the inside of the uterus. When the endometrium becomes abnormal the cells over grow inside the uterus leading to formation of hyperplasia (crowded abnormal cells) and ultimately cancer. While endometrial cancer is often curable if detected in early stages, the side-effects of current therapies (surgery, radiation and chemotherapy) can have life-long debilitating effects. These standard treatments may be ineffective in patients with later stages of endometrial cancer, where the disease has returned or spread to other organs.
Currently, patients in their child-bearing years who would prefer to preserve their uterus often have no choice but to undergo a hysterectomy, destroying their fertility.